Cite
HARVARD Citation
Milazzo, L. et al. (n.d.). SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. Journal of antimicrobial chemotherapy. pp. 1155-1160. [Online].